Dextromethorphan modulates the AP-1 DNA-binding activity induced by kainic acid

Brain Res. 1999 Apr 3;824(1):125-32. doi: 10.1016/s0006-8993(99)01155-5.

Abstract

We have recently reported that dextromethorphan attenuates the neurotoxicity induced by kainic acid in a dose-related fashion. Pretreatments with dextromethorphan (50 mg/kg, p.o. x2) significantly reduced the activator protein-1 DNA-binding activity and the Fos-related antigen-immunoreactive protein induced by kainic acid (10 mg/kg, i.p.) in the CA1, but not the CA3 or the dentate gyrus sector of the rat hippocampus. Paradoxically, dextromethorphan itself caused an elevated activator protein-1 DNA-binding activity and Fos-related antigen-immunoreactive protein in the CA1 region which lasted for at least 4 days. The results suggest that the CA1 area is the critical site for mediating the putative neuroprotective effect induced by dextromethorphan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA / metabolism*
  • Dextromethorphan / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Kainic Acid / pharmacology*
  • Male
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Tissue Distribution / physiology
  • Transcription Factor AP-1 / metabolism*

Substances

  • Excitatory Amino Acid Antagonists
  • Proto-Oncogene Proteins c-fos
  • Transcription Factor AP-1
  • Dextromethorphan
  • DNA
  • Kainic Acid